Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocol.
Saved in:
| Title: | Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocol. |
|---|---|
| Authors: | Tan NH; Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, Netherlands., Sablerolles RSG; Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, Netherlands., Rietdijk WJR; Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, Netherlands., Goorhuis A; Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, Amsterdam, Netherlands.; Infection & Immunity, Amsterdam Public Health, University of Amsterdam, Amsterdam, Netherlands., Postma DF; Department of Internal Medicine and Infectious Diseases, University Medical Center Groningen, Groningen, Netherlands., Visser LG; Department of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands., Bogers S; Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands., Geers D; Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands., Zaeck LM; Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands., Koopmans MPG; Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands., Dalm VASH; Department of Internal Medicine, Division of Allergy & Clinical Immunology and Department of Immunology, Erasmus Medical Center, Rotterdam, Netherlands., Kootstra NA; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Infection and Immunity Institute, University of Amsterdam, Amsterdam, Netherlands., Huckriede ALW; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., van Baarle D; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands., Lafeber M; Department of Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands., GeurtsvanKessel CH; Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands., de Vries RD; Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands., van der Kuy PM; Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, Netherlands. |
| Source: | Frontiers in immunology [Front Immunol] 2022 Nov 29; Vol. 13, pp. 1067749. Date of Electronic Publication: 2022 Nov 29 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
